A new clinical trial has found that an extract of Rhodiola rosea roots and rhizomes demonstrated anti-depressive activity in patients with mild to moderate depression. This is the first double-blind, randomized, placebo-controlled study of Rhodiola rosea in patients diagnosed with depression. Patients given the Swedish-made Rhodiola rosea extract showed significant improvements in depression compared to those given placebo. [click link for full article]
Popularity: unranked [?]
Related posts:
- Swedish Rhodiola Rosea Extract Effective In Treating Mild To Moderate Depression In New Clinical Trial
- Extract Of Kava Useful In Treating Anxiety And Improving Mood
- DOV Pharmaceutical, Inc. Initiates Phase II Clinical Trial In Patients With Major Depressive Disorder
- Medication Effective In Treating Depression In Patients With Coronary Artery Disease
- New Phase 3 Data Showed PRISTIQ Significantly Reduced Symptoms Of Major Depressive Disorder Versus Placebo
Comments
No Responses to “Swedish Rhodiola Rosea Extract Effective In Treating Mild To Moderate Depression In New Clinical Trial”